Spectrum Pharmaceuticals, Inc. 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-04-30 4:11 pm Sale | 2021-04-26 | 13D | CASI Pharmaceuticals, Inc. CASI | SPECTRUM PHARMACEUTICALS INC SPPI | 688,696 4.900% | -234,736 (-25.42%) | Filing |
| 2020-08-18 4:04 pm Purchase | 2020-08-18 | 13D | CASI Pharmaceuticals, Inc. CASI | SPECTRUM PHARMACEUTICALS INC SPPI | 923,432 7.500% | 923,432 (New Position) | Filing |